Chengdu Xiling Power Scien (300733.SZ) traded flat 0 % during a 24 hours period ending at 10:47 PM Central Europe on Tuesday 27th. One Chengdu Xiling Power Scien stock can currently be bought for about CNY 13.05 on popular exchanges. Current supply of Chengdu Xiling Power Scien stocks is 396.6 mn. Chengdu Xiling Power Scien has a current market capitalization of CNY 5.3 bn and approximately CNY 61.9 mn worth of Chengdu Xiling Power Scien was traded on exchanges in the last 24 hours. Since last month end, Chengdu Xiling Power Scien has traded 3.8 % up. Simple moving average of last 200 days is at CNY 13.54. The highest price of past 52 weeks was recorded at CNY 16.67 on 04/30/2026. 52 weeks low was at CNY 10.71 on 07/14/2026.
Summary of the latest news for Chengdu Xiling Power Scien
CHENGDU XILING POWER SCIEN has not been mentioned in the provided information. Therefore, no summary can be generated.
Here is how related stocks have performed in the past 24 hours:
Motic Xiamen Electric-grou (300341.SZ) traded flat 0 % and now trades at CNY 12.25. Current market capitalisation for Motic Xiamen Electric-grou is CNY 6.3 bn. Current price/earnings ratio for Motic Xiamen Electric-grou is 32.09.
Chengdu Kanghua Biological (300841.SZ) traded flat 0 % and now trades at CNY 46.88. Chengdu Kanghua Biological has a market capitalisation of CNY 6.4 bn. Chengdu Kanghua Biological has a current price to earnings ratio of 26.78.
Hob Biotech Suzhou C (688656.SS) traded flat 0 % and now trades at CNY 100.63. Hob Biotech Suzhou C has a market capitalisation of CNY 6.4 bn. Hob Biotech Suzhou C has a current price to earnings ratio of 252.4.
Zkteco (301330.SZ) traded flat 0 % and now trades at CNY 25.77. Zkteco has a market capitalisation of CNY 6.4 bn. Current price/earnings ratio for Zkteco is 29.36.
Shenzhen Tagen (000090.SZ) traded flat 0 % and now trades at CNY 3.28. Shenzhen Tagen has a market capitalisation of CNY 6.4 bn. Shenzhen Tanjian Group Co., a key construction and real‑estate developer in Shenzhen, reported its first‑quarter‑to‑third‑quarter results for 2026. The company’s revenue fell modestly, driven by a continued slowdown in the construction market, while costs rose, leading to a significant decline in gross margin. Operating profit turned negative, and the company recorded a net loss that marked a steep deterioration from prior years. Its balance sheet shows a modest reduction in short‑term borrowing and an increase in long‑term debt, indicating a shift toward longer‑dated financing. Overall, the firm’s financial performance has weakened markedly, reflecting the broader challenges facing the construction industry, while its credit rating remains stable due to strong project pipelines and government contracts.